https://ctv.veeva.com/study/safety-immunogenicity-efficacy-of-ad26mos4hiv-mva-bn-hiv-and-pgt121-pgdm1400-and-vrc07-523ls?comeFrom=%7B%22type%22%3A%22site%22%2C%22slug%22%3A%22orlando-immunology-center-orlando-fl%22%7D
Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS...
A multicenter, randomized, parallel-group, placebo-controlled, double-blind, Phase 1/2a clinical study to investigate the safety, tolerability, immunogenicity...
https://insight.jci.org/assets/63617/powerpoint
JCI Insight - Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on...